Intraocular pressure lowering effect of Lataprost eye drop with once every other day dosing

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201108254166N4

Enrollment

Registered

2011-12-03

Start date

2011-04-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma. Glaucoma

Interventions

Treatment - Drugs

in the 2nd phase the same patients receive the drug with once every other day dose.

The design of this study is cross over

in the 1st phase patients as case group receive the lataprost 0.005%with once daily dosage

in the 2nd phase the same patients receive the drug with once every other day dose..

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Administering eye drop Lataprost % one time at night 2. At least two prior IOP checking in recent month 3. Appropriate IOP control with present medications 4. No prior intraocular surgery Exclusion criteria: 1. Glaucoma surgery 2. Incomplete response to 2 antiglaucoma 3. Not possible to follow-up 4. Corneal problem that interferes with IOP checking 5. Ocular problem except cataract & glaucoma

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Intraocular Pressure. Timepoint: 0, 1, 2, 4, 6, 8 and 12 weeks after. Method of measurement: Goldmann applanation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Amizadeh

Tabriz University of medical Sciences

yashar.amizadeh@gmail.com+98 41 1655 1332

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026